
|Articles|April 29, 2013
Essilor, HPO enter exclusive global license agreement
Advertisement
Charenton le Pont, France-Essilor has signed an exclusive and global license agreement with High Performance Optics (HPO), that complements its existing patent and technologies portfolio. This license agreement will allow Essilor to continue to focus on products with correction and preventive benefits and to roll out its portfolio of products around the world.
The pact enables Essilor to strengthen its mission of reaching the 4.2 billion people worldwide who need vision correction.
As a result of the company’s R&D and innovation processes, Essilor currently has approximately 5,600 patents throughout the world that help extend its strategy.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Optometry Times - Clinical News & Expert Optometrist Insights
1
Study finds no link between semaglutide and a blinding form of macular degeneration
2
Euclid Vision receives FDA clearance for Be Free Day toric contact lenses
3
Oculis enrolls first patient in licaminlimab PREDICT-1 DED trial
4
Five pillars of a strong OD/MD partnership
5





















